An open-label, two-treatment, two-sequence, two-period, balanced, randomized, single dose, cross over, comparative bioavailability study of ZYO1 tablet [20mg tablet and 5mg tablet - old (first) formulation] of M/S Cadila Healthcare Ltd., Ahmedabad, India with ZYO1 tablet [20 mg tablet and 5 mg tablet - new (second) formulation] of M/S Cadila Healthcare Ltd., Ahmedabad, India in healthy, adult, male, human subjects under fasting conditions.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 30 Aug 2016

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com